ea0010p77 | Steroids to include Cushing's | SFE2005
Abdulali A
, Martin N
, Dhillo W
, Banerjee A
, Jayasena C
, Todd J
, Meeran K
The rising prevalence of obesity and type II diabetes makes the diagnosis of Cushings syndrome increasingly difficult. The dexamethasone-suppressed corticotrophin-releasing hormone (CRH) test, which involves CRH administration immediately following a standard low dose dexamethasone suppression test (LDDST), has been reported to diagnose Cushings syndrome with 100% sensitivity and specificity. We adapted our LDDST protocol to include CRH administration post-dexameth...